Medicare Enrolled
Dr. Daniel Niknam, DO
Internal Medicine · Inglewood, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Niknam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Niknam?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Niknam
Dr. Daniel Niknam is an internal medicine specialist in Inglewood, CA, with 7 years of NPI registration. Based on federal Medicare data, Dr. Niknam performed 6,465 Medicare services across 2,445 unique beneficiaries.
Between the years covered by Open Payments, Dr. Niknam received a total of $4,046 from 37 pharmaceutical and/or device companies across 173 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Niknam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 7 years in practice
▲ Top 4% volume in CA
$4,046 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,465
Medicare services
Top 4% in CA for internal medicine
2,445
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~924 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,610 | $66 | $150 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
1,135 | $60 | $142 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
989 | $98 | $306 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
662 | $102 | $250 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
492 | $143 | $469 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
428 | $151 | $339 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
287 | $88 | $187 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
285 | $67 | $422 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
265 | $105 | $264 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
106 | $111 | $267 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
94 | $41 | $100 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
56 | $30 | $94 |
| Home visit, new patient, moderate complexity A home visit for a new patient involving moderate medical decision making, lasting at least 60 minutes. |
23 | $117 | $377 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $124 | $350 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
11 | $64 | $179 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,046
Total received (2021-2024)
Avg $1,012/year across 4 years
Top 18% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
173
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,046 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,367
2023
$1,073
2022
$998
2021
$608
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$173
GlaxoSmithKline, LLC.
$152
Novartis Pharmaceuticals Corporation
$139
Bayer Healthcare Pharmaceuticals Inc.
$122
PFIZER INC.
$113
Otsuka America Pharmaceutical, Inc.
$103
GENZYME CORPORATION
$98
AstraZeneca Pharmaceuticals LP
$70
Amgen Inc.
$68
Actelion Pharmaceuticals US, Inc.
$61
Mannkind Corporation
$47
Mallinckrodt Hospital Products Inc.
$34
Baxter Healthcare
$31
SCILEX PHARMACEUTICALS INC.
$24
Insmed, Inc.
$23
Electromed, Inc.
$23
Lundbeck LLC
$20
ABBVIE INC.
$20
Janssen Pharmaceuticals, Inc
$19
Lilly USA, LLC
$14
Xeris Pharmaceuticals, Inc.
$13
Top 3 companies account for 33.9% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$399
Novartis Pharmaceuticals Corporation
$374
Actelion Pharmaceuticals US, Inc.
$334
GlaxoSmithKline, LLC.
$296
Regeneron Healthcare Solutions, Inc.
$196
GENZYME CORPORATION
$191
Mallinckrodt Hospital Products Inc.
$180
Boehringer Ingelheim Pharmaceuticals, Inc.
$173
Baxter Healthcare
$168
Lilly USA, LLC
$164
Otsuka America Pharmaceutical, Inc.
$159
Janssen Pharmaceuticals, Inc
$153
BIOTISSUE HOLDINGS, INC.
$136
PFIZER INC.
$132
Advanced Respiratory, Inc
$124
Bayer Healthcare Pharmaceuticals Inc.
$122
SANOFI-AVENTIS U.S. LLC
$94
Amgen Inc.
$68
Alexion Pharmaceuticals, Inc.
$64
Sun Pharmaceutical Industries Inc.
$54
Insmed, Inc.
$51
Mannkind Corporation
$47
Merck Sharp & Dohme LLC
$46
Mylan Specialty L.P.
$40
Xeris Pharmaceuticals, Inc.
$36
Eisai Inc.
$35
Sunovion Pharmaceuticals Inc.
$31
SCILEX PHARMACEUTICALS INC.
$24
Electromed, Inc.
$23
Scilex Pharmaceuticals Inc.
$21
Lundbeck LLC
$20
ABBVIE INC.
$20
EISAI INC.
$17
Nabriva Therapeutics, plc
$16
Dexcom, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$14
Sumitomo Pharma America, Inc.
$12
Top 3 companies account for 27.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFREZZA · AIRSUPRA · APTIOM · Aduhelm · Arikayce · BEVESPI AEROSPHERE · BLU-U · BREZTRI · DUPIXENT · Dexcom G6 Transmitter · ENTRESTO · FARXIGA · FASENRA · GEMTESA · GVOKE PFS · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · JARDIANCE · KEVEYIS · Kerendia · LEQVIO · LINZESS · LOKELMA · MOUNJARO · NEOX · NUCALA · OFEV · OPSUMIT · OXBRYTA · Odomzo · PAXLOVID · REXULTI · SEGLENTIS · SHINGRIX · SMARTVEST · SOLIQUA 100/33 · Soliris · TEPEZZA · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TRULICITY · The Vest System Model 105 Home Care · UPTRAVI · VERQUVO · XARELTO · Xenleta · Yupelri · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
4,891
Per 100K population
49.7
County median income
$87,760
Nearest hospital
CENTINELA HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Niknam is a clinical cardiology specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement in the top 18% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Niknam experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Niknam performed 1,610 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Niknam receive payments from pharmaceutical companies?
Yes. Dr. Niknam received a total of $4,046 from 37 companies across 173 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Niknam's costs compare to other internal medicine physicians in Inglewood?
Dr. Niknam's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Niknam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Inglewood
Browse internal medicine physicians in Inglewood ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology